Pricing Log in Create free account

Janux Therapeutics, Inc. (JANX) vs OmniAb, Inc. (OABI)

Janux Therapeutics, Inc. and OmniAb, Inc. are both Biotechnology companies. Janux Therapeutics, Inc. and OmniAb, Inc. are of similar size ($758.1M and $743.9M). Janux Therapeutics, Inc. grew revenue faster over the last twelve months: 214.4% against 90.6%. OmniAb, Inc. has the higher net margin (−108.1% vs −300.0%) and the lower return on invested capital (−15.8% vs 0.00%). Across the 16 metrics below, Janux Therapeutics, Inc. leads on 8 and OmniAb, Inc. on 8.

Valuation

Metric JANX OABI Biotechnology median
P/E n/m n/m 11.58
P/S 23.60 16.33 9.61
P/B 0.86 2.64 2.26
Price to free cash flow n/m 275.97 26.41
EV/EBITDA 1.07 n/m 0.72
EV/Sales (4.81) 14.74 9.43
Earnings yield (12.77%) (6.69%) (32.28%)
Free cash flow yield (6.90%) 0.36% (22.27%)

Profitability

Metric JANX OABI Biotechnology median
Gross margin 100.00% 97.65% 68.81%
Operating margin (419.24%) (115.89%) 0.00%
Net margin (299.95%) (108.11%) 0.00%
Free cash flow margin (162.70%) 5.92% 0.00%
Return on equity (10.58%) (16.51%) (50.30%)
Return on assets (9.94%) (14.48%) (45.47%)
Return on invested capital 0.00% (15.75%) 0.00%

Growth

Metric JANX OABI Biotechnology median
Revenue growth (TTM) 214.40% 90.63% 6.78%
EPS growth (last fiscal year) (42.97%) 6.56% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric JANX OABI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 17.69 4.21 4.74
Net debt to EBITDA 5.58 1.12 1.01

Dividend

Metric JANX OABI Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric JANX OABI Biotechnology median
Market cap 758.06m 743.89m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack